News

Healthcare

Pharma Boss Charged With Penny Stock Fraud

Cameron Samuel | Equities.com |

The pharma monolith allegedly promoted two penny stocks with "a group of prolific South Florids-based microcap fraudsters", said the SEC.


AP Exclusive: Stable Costs May Shift 'Obamacare' Politics

Associated Press | Equities.com |

The steady outlook means the health care law won't be an easy target for Republicans this year, an election issue that's worked well for them since 2010.


Amazon’s New Business Investment: What it Means for Healthcare & The Economy

Andrew Deen | Equities.com |

Amazon is eyeing the $400 billion U.S. pharmaceutical market, but its approach is somewhat unconventional.


How Tech is Changing How Healthcare Must Communicate With Patients

Visual Capitalist | Equities.com |

Technology has changed how consumers access health information – and if health companies don’t pivot to a better content strategy, they will get left behind.


Investors Have Misdiagnosed Amazon’s Push Into the Pharmacy Business

Vitaliy Katsenelson | Equities.com |

Companies everywhere, in every business, are paranoid about Amazon. This sort of paranoia is healthy for the long-term well-being of our investment portfolio, as it is creating interesting buying opportunities.


Becton, Dickinson’s Stock Gains 1.5% on Friday

Alex Hamilton | Equities.com |

The company’s third-quarter saw revenue rise in the mid-single digits for all three segments of the business.


Healthcare Sector 3Q18: Best and Worst

David Trainer | Equities.com |

The Healthcare sector ranks fourth out of the 11 sectors. Here's why.


Renovia Raises $42.3 Million Series B for Pelvic Floor Disorders

Edward Kim | Equities.com |

The company markets the leva pelvic floor muscle training system to help patients maintain continence (Image: Renovia).


Fate Therapeutics Collaborating on New Cancer Treatment

Brian O'Connell | Equities.com |

The partnership between the research team at the University of Minnesota and Fate Therapeutics is looking at a new course of cancer treatment, which focuses on the use of natural killer (NK) cells.


Icahn’s Letter Against the CI-ESRX Merger is Self-Serving

Lawrence Meyers | Equities.com |

There's something fishy about Carl Icahn's open letter to Cigna shareholders, urging them to vote against the merger with Express Scripts .



Discover: Trending Events

United Nations
EU Parliament
Humanity 2.0
World Economic Forum